C
1.43
0.01 (0.70%)
| Previous Close | 1.42 |
| Volume | 314,379 |
| Price / Book | 0.830 |
| 52 Weeks Range |
| Profit Margin | -200.58% |
| Operating Margin (TTM) | -276.55% |
| Diluted EPS (TTM) | -2.17 |
| Quarterly Revenue Growth (YOY) | -18.30% |
| Current Ratio (MRQ) | 9.78 |
| Operating Cash Flow (TTM) | -19.00 M |
| Levered Free Cash Flow (TTM) | -11.99 M |
| Return on Assets (TTM) | -56.19% |
| Return on Equity (TTM) | -93.42% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | CervoMed Inc. | Mixed | Bullish |
AIStockmoo Score
| Value 35% | -1.7 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | -1.7 |
| Timing 35% | -1.5 |
| AI Technical info | NA |
| Technical Oscillators info | -2.5 |
| Technical Moving Averages info | 0.0 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| Environment | ×1.21 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | -17.9% |
| Pillar Agreement | ×1.25 |
| Not in score | |
| Price Volatility info | 1.4 |
| Final Score | -1.70 |
Select this tab to load the latest available analysis.
|
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 33.38% |
| % Held by Institutions | 26.31% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Thompson Davis & Co., Inc. | 30 Sep 2026 | 25,900 |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |